Pfizer’s respiratory syncytial virus (RSV) vaccine Abrysvo has shown efficacy in immunocompromised adults, the pharma announced Monday. In substudy B of Pfizer’s ongoing Phase 3 MONeT trial, Abrysvo ...
NEW YORK & BOTHELL, Wash.--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will ...
There is no guarantee that Pfizer/BioNTech's COVID-19 vaccine will be distributed in English care homes but the health service and regulator are working to make it possible, deputy Chief Medical ...
Pfizer expects to launch Zavicefta in additional markets outside the U.S. throughout 2017 and 2018. Zavicefta was developed in response to the urgent medical need for new antibiotics for ...
To this end, Pfizer—best known for its pioneering COVID-19 vaccine—has launched PfizerForAll, a user-friendly digital platform designed to make accessing healthcare and managing health and wellness ...
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President ...
President Donald Trump announced Tuesday that he has secured a deal with drugmaker Pfizer to lower its drug prices. There ...
Proposed acquisition to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer’s pipeline Transaction valued at $47.50 per Metsera share in cash upon closing, for an ...
They have applied for US Food and Drug Administration (FDA) approval, with a decision due by June 2026. Yet Arvinas will now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback